1. The influence of anti-rheumatic drugs on hepatic mRNA levels of acute-phase proteins in rats with adjuvant arthritis
- Author
-
B. Jagher, Irmgard Wiesenberg, Tscherry Bj, T Geiger, and Werner Pignat
- Subjects
Male ,medicine.medical_specialty ,Cyclophosphamide ,medicine.medical_treatment ,Prednisolone ,Immunology ,Indomethacin ,Down-Regulation ,Pharmacology ,Toxicology ,Fibrinogen ,Internal medicine ,medicine ,Animals ,Pharmacology (medical) ,RNA, Messenger ,biology ,business.industry ,Albumin ,Acute-phase protein ,Arthritis, Experimental ,Rheumatology ,Rats ,Endocrinology ,Cytokine ,Liver ,Rats, Inbred Lew ,biology.protein ,Cyclosporine ,Cyclooxygenase ,business ,medicine.drug ,Acute-Phase Proteins - Abstract
Using specific cDNA probes, we have investigated drug-induced changes in hepatic mRNA levels of the major acute-phase proteins (APP) fibrinogen, alpha 2-macroglobulin (alpha 2-MG), albumin and alpha 1-acid glycoprotein (alpha 1-AGP) in male Lewis rats with adjuvant arthritis. Test compounds were given orally from day 0 to 20 and hepatic mRNA analysis was performed at day 21. Prednisolone (1, 3, 10 mg/kg), Cyclosporine A (1, 3, 10 mg/kg) and cyclophosphamide (3 mg/kg) dose-dependently normalized hepatic mRNA levels of all four APP. Equipotent anti-inflammatory doses of indomethacin (0.3, 1 mg/kg) significantly downregulated alpha 2-MG mRNA levels but were much less effective in influencing albumin and alpha 1-AGP mRNA levels and even slightly increased hepatic fibrinogen mRNA levels. These results suggest that cytokine over-production, which is thought to be responsible for the acute-phase response in rats with adjuvant arthritis, can be effectively downregulated by immunosuppressive drugs, but is distinctly less affected by the cyclooxygenase inhibitor indomethacin.
- Published
- 1993